PWW
VRTX icon

Pettyjohn Wood & White’s Vertex Pharmaceuticals VRTX Stock Holding History

Pettyjohn Wood & White’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-889
Closed -$358K – 199
2024
Q4 		$358K Hold
889
– – 0.07% 151
2024
Q3 		$413K Hold
889
– – 0.08% 140
2024
Q2 		$417K Buy
889
+50
+6% +$21.7K 0.08% 135
2024
Q1 		$351K Sell
839
-28
-3% -$11.8K 0.07% 148
2023
Q4 		$353K Hold
867
– – 0.08% 145
2023
Q3 		$301K Hold
867
– – 0.07% 149
2023
Q2 		$305K Sell
867
-23
-3% -$7.75K 0.07% 147
2023
Q1 		$280K Hold
890
– – 0.07% 146
2022
Q4 		$257K Hold
890
– – 0.06% 150
2022
Q3 		$258K Hold
890
– – 0.07% 147
2022
Q2 		$251K Buy
+890
New +$238K 0.06% 152

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return